Risk factors of recurrent non-functioning pituitary adenomas in patients with growth hormone deficiency

Abstract

Background. Nowadays, a search for diagnostically significant markers of aggressiveness of non-functioning pituitary adenomas remains relevant for further prognosis in the postoperative period. Non-functioning pituitary adenomas without pituitary hypersecretion are the forms of adenohypophysis tumors. In the general population, frequency of non-functioning pituitary adenomas is 50 cases per 1 million people. The purpose of the study is to determine the clinical diagnostic markers of tumor aggressiveness in patients with non-functio­ning pituitary adenomas and growth hormone deficiency, as well as their role in the severity of the neuroendocrine symptoms of the disease. Materials and methods. Under our supervision, there were 87 patients (44 men, 43 women), of them 31 with a verified diagnosis of non-functioning pituitary adenomas after transnasal hypophysectomy. Follow-up was from 1 to 3 years. Results. When patients were distributed in groups depending on histological description of non-functioning pituitary adenomas, those with chromophobe pituitary adenoma prevailed (77.5 %). Non-functioning pituitary ade­nomas in women were associated with obesity, primary and secondary hypothyroidism, secondary hypogonadism, syndrome of persistent galactorrhea-amenorrhea (symptomatic and idiopathic forms), diabetes insipidus, empty sella syndrome and others. In men, non-functioning pituitary adenomas was accompanied by obesity, primary and secondary hypothyroidism, secondary hypogonadism, diabetes insipidus, gynecomastia. The scale developed to determine the markers of aggressiveness of non-functioning pituitary adenomas allowed identifying factors by 3 degrees and developing a set of measures to prevent the recurrence of tumor growth. Conclusions. Markers of aggressiveness of non-functioning pituitary adenomas are: young age of the patient, first symptoms of the disease, large tumor sizes, asymmetry and deformation of the pituitary gland, signs of tumor invasion into adjacent tissues/arteries/cavernous sinus, small cell and/or dark cell chromophobe adenomas, panhypopituitarism.

Authors and Affiliations

Yu. М. Urmanova, M. Yu. Shakirova, N. T. Rikhsieva, F. S. Khodgaeva

Keywords

Related Articles

Diabetes Mellitus Type 2: How to Avoid Errors and to Increase the Effectiveness of Rreatment

The article considers the urgency of the problem of diabetes mellitus incidence (DM) in the world today. It is emphasized that at the present stage of development of diabetology main goal of DM treatment is to achieve bl...

Nuances of insulin therapy in the treatment of the diabetic ketoacidosis

Background. The well-defined program of the insulin therapy is a guarantee of efficient treatment of a patient with the diabetic ketoacidosis. The approaches to the treatment varied depending on the gained experience, ho...

Effect of Combination Therapy with Alpha-Lipoic Acid on the Fractalkine Level in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus

Background. The aim of research — ​to assess the fractalkine levels in patients with coronary artery disease (CAD), depending on the presence of type 2 diabetes mellitus (DM) and the nature of coronary artery lesions bef...

Influence of nutrient correction on adiponectin circulating level and cardiovascular risk factors in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease

Aim — to evaluate the influence of dietary recommendations on adiponectin circulating level and haemodynamic characteristics in patients with type 2 diabetes mellitus (DM) and non-alcoholic fatty liver disease. Materials...

Application of antioxidant preparation Hepaval in rational therapy of diabetes mellitus

Lecture presents the data on the current state of diabetes mellitus problem and the role of oxidative stress. In diabetes mellitus, there are ideal conditions for the development of oxidative stress, the main role in whi...

Download PDF file
  • EP ID EP605117
  • DOI 10.22141/2224-0721.15.2.2019.166100
  • Views 68
  • Downloads 0

How To Cite

Yu. М. Urmanova, M. Yu. Shakirova, N. T. Rikhsieva, F. S. Khodgaeva (2019). Risk factors of recurrent non-functioning pituitary adenomas in patients with growth hormone deficiency. Міжнародний ендокринологічний журнал, 15(2), 106-110. https://europub.co.uk/articles/-A-605117